Analysts Set Celldex Therapeutics, Inc. (NASDAQ:CLDX) Price Target at $53.90
Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) have received an average rating of “Moderate Buy” from the ten ratings firms that are currently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy […]
Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) have received an average rating of “Moderate Buy” from the ten ratings firms that are currently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy […]
